Starling Oncology STLN Income Statement (2019-2026)

NASDAQ STLN
$5.99 -0.11 (-1.72%)
As of: Sep 3, 2026 · 1:58 PM EDT
Reported Financials

Starling Oncology Quarterly Income Statement

Periods 27 quarters
Latest Jun 2026

Starling Oncology reported revenue of $161.28M and net income of -$9.79M for the quarter ended Jun 2026, up 34.6% year over year. This income statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
52.27M52.30M55.16M60.92M64.98M71.42M76.19M80.22M82.03M85.79M94.67M98.58M99.90M100.27M104.41M119.80M136.56M141.96M147.44M161.28M
Cost of RevenueCost of Rev
25.39M27.35M27.38M32.88M36.13M38.38M42.81M44.88M44.96M48.36M49.50M46.52M85.53M-66.90M87.16M102.30M117.64M-86.54M124.13M134.12M
Gross Profit
26.88M24.95M27.78M28.05M28.85M33.04M33.38M35.35M37.07M37.42M45.17M52.06M14.37M167.17M17.25M17.50M18.92M228.50M23.32M27.16M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.23M0.26M0.31M0.36M0.39M0.46M0.54M0.60M0.91M0.81M0.71M0.74M0.80M0.93M1.01M1.03M1.01M0.92M0.90M1.12M
Selling, General & AdministrativeSG&A
12.73M48.24M29.81M28.35M31.96M29.57M28.83M28.73M28.20M28.09M28.45M27.87M26.65M24.86M25.38M26.91M25.25M28.04M28.21M29.94M
Other Operating ExpensesOther Opex
41.48M44.63M43.51M50.52M52.72M66.47M79.69M65.83M66.84M72.18M83.47M86.33M86.31M86.41M87.93M103.07M118.36M119.91M124.84M134.83M
Operating ExpensesOpex
54.43M93.14M73.63M79.22M85.07M96.50M109.06M95.16M95.96M101.08M112.64M114.94M113.75M112.20M114.32M131.01M144.62M148.86M153.95M165.90M
Operating IncomeOp. Inc
-2.16M-40.83M-18.47M-18.30M-20.10M-25.08M-32.87M-14.94M-13.93M-15.29M-17.97M-16.36M-13.85M-11.93M-9.91M-11.21M-8.05M-6.91M-6.51M-4.62M
EBIT
-2.16M-40.83M-18.47M-18.30M-20.10M-25.08M-32.87M-14.94M-13.93M-15.29M-17.97M-16.36M-13.85M-11.93M-9.91M-11.21M-8.05M-6.91M-6.51M-4.62M
Non-operating items
Non Operating Interest Expenses
0.07M0.06M1.64M1.75M1.94M1.99M2.12M2.23M1.17M5.57M1.87M1.92M1.92M1.93M1.86M
Interest & Investment IncomeInt & Inv Inc
0.01M1.21M1.03M0.94M
Other Non Operating IncomeOther Non Op Inc.
0.05M-0.23M0.18M0.01M15.51M8.69M3.32M-0.36M-1.28M-1.16M0.07M2.57M-0.06M0.13M-3.31M-3.99M-5.98M1.07M5.00M-3.24M
Non Operating IncomeNon Op. Inc.
-0.02M28.21M37.94M12.82M17.40M13.71M2.91M-1.86M-3.36M-3.78M-1.92M0.89M-2.26M-1.25M-9.67M-5.93M-8.45M-0.60M4.02M-5.17M
Net income details
EBT
-2.18M-12.62M19.47M-5.49M-2.70M-11.37M-29.95M-16.80M-17.28M-19.07M-19.89M-15.48M-16.11M-13.18M-19.59M-17.14M-16.50M-7.51M-2.49M-9.79M
Tax ProvisionsTaxes
0.80M-2.47M0.18M-0.03M-0.02M-0.37M0.04M0.10M0.14M-0.31M-0.13M
Profit After TaxPAT
-2.98M-10.16M19.29M-5.45M-2.67M-28.14M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M-9.79M
Income from Continuing OperationsIncome (Continuing)
-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M-9.79M
Consolidated Net IncomeConsol Net Inc.
-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M-9.79M
Income towards Parent CompanyParent Net Inc
-2.98M-10.16M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-15.48M-16.11M-13.18M-19.59M-17.01M-16.50M-7.51M-2.49M-9.79M
Net Income towards Common StockholdersNet Income
-0.35M-9.93M19.29M-5.45M-2.67M-11.01M-30.00M-16.90M-17.42M-18.75M-19.89M-12.68M-13.22M-10.83M-16.07M-13.99M-13.77M-6.43M-2.09M-8.24M
Additional items
EPS (Basic)
-0.01-0.150.26-0.07-0.04-0.15-0.41-0.23-0.24-0.25-0.27-0.17-0.18-0.14-0.21-0.15-0.14-0.07-0.02-0.08
EPS (Diluted)
-0.01-0.150.25-0.07-0.03-0.14-0.41-0.23-0.24-0.25-0.27-0.17-0.18-0.14-0.21-0.15-0.14-0.07-0.02-0.08
Shares Outstanding
28.75M66.23M73.25M73.00M72.18M72.79M73.45M74.12M73.47M73.75M74.23M74.75M75.52M75.04M77.10M93.20M97.47M92.39M101.80M103.03M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
28.75M66.23M76.25M73.00M79.58M80.61M73.45M74.12M73.47M73.75M74.23M74.75M75.52M75.04M77.10M93.20M97.47M92.39M101.80M103.03M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
28.75M73.25M73.28M71.98M72.34M73.27M73.75M72.96M73.73M74.15M74.31M75.49M75.56M75.74M88.93M93.28M97.57M98.86M99.97M100.47M
EBITDA
-1.93M-40.57M-18.16M-17.95M-19.70M-24.62M-32.33M-14.34M-13.01M-14.48M-17.26M-15.62M-13.05M-11.00M-8.90M-10.18M-7.05M-5.99M-5.61M-3.49M
Interest ExpensesInt Expense
0.07M0.06M1.64M1.75M1.94M1.99M2.12M2.23M1.17M5.57M1.87M1.92M1.92M1.93M1.86M
Tax Rate
-36.63%19.55%0.92%0.58%0.89%3.23%-0.15%-0.59%-0.78%1.65%0.76%